These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24566182)

  • 1. The emergence of linezolid resistance among Enterococci in intestinal microbiota of treated patients is unrelated to individual pharmacokinetic characteristics.
    Bourgeois-Nicolaos N; Nguyen TT; Defrance G; Massias L; Alavoine L; Lefort A; Noel V; Senneville E; Doucet-Populaire F; Mentré F; Andremont A; Duval X
    Antimicrob Agents Chemother; 2014 May; 58(5):2681-7. PubMed ID: 24566182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and microbiologic efficacy and safety profile of linezolid, a new oxazolidinone antibiotic.
    Corti G; Cinelli R; Paradisi F
    Int J Antimicrob Agents; 2000 Dec; 16(4):527-30. PubMed ID: 11118873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linezolid: a review of its use in the management of serious gram-positive infections.
    Perry CM; Jarvis B
    Drugs; 2001; 61(4):525-51. PubMed ID: 11324682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of linezolid in antimicrobial therapy].
    Carmona PM; Romá E; Monte E; García J; Gobernado M
    Enferm Infecc Microbiol Clin; 2003 Jan; 21(1):30-41. PubMed ID: 12550042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of linezolid in the therapy of infections caused by multiresistant gram-positive cocci].
    Paradisi F; Corti G
    Infez Med; 2004 Mar; 12(1):19-26. PubMed ID: 15329525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linezolid: the first oxazolidinone antimicrobial.
    Moellering RC
    Ann Intern Med; 2003 Jan; 138(2):135-42. PubMed ID: 12529096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New treatment option for gram-positive infections in critically ill patients - overview over linezolid].
    Krueger WA; Unertl KE
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Apr; 37(4):199-204. PubMed ID: 11967745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms.
    Mendes RE; Deshpande LM; Jones RN
    Drug Resist Updat; 2014 Apr; 17(1-2):1-12. PubMed ID: 24880801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linezolid, the first oxazolidinone antibacterial agent.
    Leach KL; Brickner SJ; Noe MC; Miller PF
    Ann N Y Acad Sci; 2011 Mar; 1222():49-54. PubMed ID: 21434942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linezolid.
    French G
    Int J Clin Pract; 2001; 55(1):59-63. PubMed ID: 11219321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linezolid for the treatment of resistant gram-positive cocci.
    Bain KT; Wittbrodt ET
    Ann Pharmacother; 2001 May; 35(5):566-75. PubMed ID: 11346064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linezolid: an oxazolidinone antimicrobial agent.
    Fung HB; Kirschenbaum HL; Ojofeitimi BO
    Clin Ther; 2001 Mar; 23(3):356-91. PubMed ID: 11318073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Linezolid, the first oxazolidinone antibiotic].
    Dutronc H; Bocquentin F; Galpérine T; Lafarie-Castet S; Dupon M
    Med Mal Infect; 2005 Sep; 35(9):427-34. PubMed ID: 16297585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the use of linezolid: a pediatric perspective.
    Tan TQ
    Pediatr Infect Dis J; 2004 Oct; 23(10):955-6. PubMed ID: 15602197
    [No Abstract]   [Full Text] [Related]  

  • 15. Linezolid-resistant clinical isolates of enterococci and Staphylococcus cohnii from a multicentre study in China: molecular epidemiology and resistance mechanisms.
    Chen H; Wu W; Ni M; Liu Y; Zhang J; Xia F; He W; Wang Q; Wang Z; Cao B; Wang H
    Int J Antimicrob Agents; 2013 Oct; 42(4):317-21. PubMed ID: 23880167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of linezolid in children: an overview of recent advances.
    Velissariou IM
    Expert Rev Anti Infect Ther; 2006 Dec; 4(6):947-52. PubMed ID: 17181410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid.
    Hachem R; Afif C; Gokaslan Z; Raad I
    Eur J Clin Microbiol Infect Dis; 2001 Jun; 20(6):432-4. PubMed ID: 11476449
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia.
    Smith PF; Birmingham MC; Noskin GA; Meagher AK; Forrest A; Rayner CR; Schentag JJ
    Ann Oncol; 2003 May; 14(5):795-801. PubMed ID: 12702536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linezolid: in infants and children with severe Gram-positive infections.
    Lyseng-Williamson KA; Goa KL
    Paediatr Drugs; 2003; 5(6):419-29; discussion 430-1. PubMed ID: 12765493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotics for gram-positive bacterial infections. Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid.
    Lundstrom TS; Sobel JD
    Infect Dis Clin North Am; 2000 Jun; 14(2):463-74. PubMed ID: 10829266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.